# Tumor-Treating Fields Alter Nanomechanical Properties of Pancreatic Ductal Adenocarcinoma Cells Co-Cultured with Extracellular Matrix

**Authors:** Tanmay Kulkarni, Sreya Banik, Debabrata Mukhopadhyay, Hani Babiker, Santanu Bhattacharya

PMC · DOI: 10.3390/jfb16050160 · Journal of Functional Biomaterials · 2025-05-03

## TL;DR

This study explores how Tumor-Treating Fields (TTFields) affect the mechanical properties of pancreatic cancer cells and their surrounding matrix.

## Contribution

The study introduces a novel co-culture system to investigate TTFields' impact on cell-matrix interactions in pancreatic cancer.

## Key findings

- TTFields increase cell membrane stiffness and reduce deformation in Panc1 and AsPC1 cells.
- TTFields significantly alter the nanomechanical properties of ECM gels co-cultured with PDAC cells.
- AsPC1 cells show more pronounced changes in response to TTFields compared to Panc1 cells.

## Abstract

Tumor-Treating Fields (TTFields), a novel therapeutic avenue, is approved for therapy in Glioblastoma multiforme, malignant pleural mesothelioma, and metastatic non-small cell lung cancer (NSCLC). In pancreatic ductal adenocarcinoma (PDAC), several clinical trials are underway to improve outcomes, yet a significant knowledge gap prevails involving the cell-extracellular matrix (ECM) crosstalk. Herein, we hypothesized that treatment with TTFields influence this crosstalk, which is reflected by the dynamic alteration in nanomechanical properties (NMPs) of cells and the ECM in a co-culture system. We employed an ECM gel comprising collagen, fibronectin, and laminin mixed in 100:1:1 stoichiometry to co-culture of Panc1 and AsPC1 individually. This ECM mixture mimics the in vivo tumor microenvironment closely when compared to the individual ECM components studied before. A comprehensive frequency-dependent study revealed the optimal TTFields frequency to be 150 kHz. We also observed that irrespective of the ECM’s presence, TTFields increase cell membrane stiffness and decrease deformation several-folds in both Panc1 and AsPC1 cells at both 48 h and 72 h. Although adhesion for AsPC1 decreased at 48 h, at 72 h it was observed to increase irrespective of ECM’s presence. Moreover, it significantly alters the NMPs of ECM gels when co-cultured with PDAC cell lines. However, AsPC1 cells were observed to be more detrimental to these changes. Lastly, we attribute the stiffness changes in Panc1 cells to the membrane F-actin reorganization in the presence of TTFields. This study paves a path to study complex PDAC TME as well as the effect of various chemotherapeutic agents on such TME with TTFields in the future.

## Linked entities

- **Diseases:** pancreatic ductal adenocarcinoma (MONDO:0005184), Glioblastoma multiforme (MONDO:0018177), malignant pleural mesothelioma (MONDO:0005112), non-small cell lung cancer (MONDO:0005233)

## Full-text entities

- **Genes:** FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}
- **Diseases:** NSCLC (MESH:D002289), PDAC (MESH:D021441), malignant pleural mesothelioma (MESH:D000086002), Tumor (MESH:D009369), Glioblastoma multiforme (MESH:D005909)
- **Cell lines:** Panc1 — Homo sapiens (Human), Pancreatic ductal adenocarcinoma, Cancer cell line (CVCL_0480), AsPC1 — Homo sapiens (Human), Pancreatic ductal adenocarcinoma, Cancer cell line (CVCL_0152)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12112427/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12112427/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12112427/full.md

---
Source: https://tomesphere.com/paper/PMC12112427